1 |
Quirk JT, Li Q, Natarajan N, Mettlin CJ and Cummings KM (2004). Cigarette smoking and the risk of bladder cancer in men and women. Tob Induc Dis, 2, 141-4.
DOI
|
2 |
Rosai J (2011) Bladder. In Rosai and Ackerman's Surgical Pathology. Rosai J editor, tenth ed. Mosby Elsevier, New York, pp1247-71.
|
3 |
Schapers RF, Pauwels RP, Wijnen JT, et al (1994). A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance and comparison with other prognostic parameters. Br J Urol, 73, 625-31.
DOI
|
4 |
Schned AR, Andrew AS, Marsit CJ, et al (2008). Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scand J Urol Nephrol, 42, 237-42.
DOI
|
5 |
Shephard EA, Stapley S, Neal RD, et al (2012). Clinical features of bladder cancer in primary care. Br J Gen Pract, 62, 598-604.
DOI
|
6 |
Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer Statistics, 2014. CA Cancer J Clin, 64, 9-29.
DOI
|
7 |
Silverman DT, Hartge P, Morrison AS and Devesa SS (1992). Epidemiology of bladder cancer. Hematol Oncol Clin North Am, 6, 1-30.
|
8 |
Skinner DG (1977). Current state of classification and staging of bladder cancer. Cancer Res, 37, 2838-42.
|
9 |
Sobin LH, Gospodarowicz MK and Wittekind C (2009). TNM Classification of Malignant Tumours, 7Th Ed. International Union against Cancer (UICC). John Wiley & Sons, Ltd., Atrium, Southern Gate, Chichester, West Sussex UK, pp262-265.
|
10 |
Stanton ML, Xiao L, Czerniak BA and Guo CC (2013) Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases. Arch Pathol Lab Med, 137, 1337-41.
DOI
|
11 |
Taylor JA 3rd and Kuchel GA (2009). Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction. Nat Clin Pract Urol, 6, 135-44.
DOI
|
12 |
Van der Heijden AG and Witjes JA (2009). Recurrence, Progression, and Follow-Up in Non-Muscle-Invasive Bladder Cancer. European Urology Supplements, 8556-562.
|
13 |
Vedder MM, Marquez M, de Bekker-Grob EW, et al (2014). Risk prediction scores for recurrence and progression of nonmuscle invasive bladder cancer: an international validation in primary tumours. PLoS One, 9, 96849.
DOI
|
14 |
Wang ZH, Li YY, Hu ZQ, et al (2012). Does urothelial cancer of bladder behave differently in young patients? Chin Med J (Engl), 125, 2643-8.
|
15 |
Akagashi K, Tanda H, Kato S,et al (2006). Recurrence pattern for superficial bladder cancer. Int J Urol, 13, 686-91.
DOI
|
16 |
Bryan RT, Collins SI, Daykin MC, et al (2010). Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surg Engl, 92, 519-24.
DOI
|
17 |
Alsheikh A, Mohamedali Z, Jones E, et al (2001). Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology. Mod Pathol, 14, 267-72.
DOI
|
18 |
Amin MB, Delahunt B, Bochner BH, et al (2014). Protocol for the examination of specimens from patients with carcinoma of the Urinary Bladder. College of American Pathologists (CAP); 1996-2010. http://www.cap.org webcite.
|
19 |
Andius P, Johansson SL, Holmang S (2007). Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion. Urology, 70, 758-62.
DOI
|
20 |
Burch JD, Rohan TE, Howe GR, et al (1989). Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer, 44, 622-8.
DOI
|
21 |
Burger M, Catto JW, Dalbagni G, et al (2013). Epidemiology and risk factors of urothelial bladder cancer. Eur Urol, 63, 234-41.
DOI
ScienceOn
|
22 |
Chamie K, Litwin MS, Bassett JC, et al (2013). Urologic Diseases in America Project. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer, 119, 3219-27.
DOI
ScienceOn
|
23 |
Cheng L, Neumann RM, Weaver AL, et al (2000). Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol, 113, 275-9.
DOI
|
24 |
Cheng L, Lopez-Beltran A, Bostwick DG (2012). Bladder cancer: general features,first ed.:A John Wiley & Sons, Inc.,New Jersey, pp138-152.
|
25 |
Eble JN, Grignon DJ and Young RH (2013). Tumors of the urinary bladder and urethra. tumors of the urinary tract. In: Fletcher CDM editor,fourt ed.Elsevier Inc., Philadelphia (PA), pp614.
|
26 |
Choi YL, Lee SH, Kwon GY,et al (2007). Overexpression of CD24: association with invasiveness in urothelial carcinoma of the bladder. Arch Pathol Lab Med, 131, 275-81.
|
27 |
Chu H, Wang M and Zhang Z (2013): Bladder cancer epidemiology and genetic susceptibility. J Biomed Res, 27, 170-8.
DOI
ScienceOn
|
28 |
DeSouza K, Chowdhury S and Hughes S (2014): Prompt diagnosis key in bladder cancer. Practitioner, 258, 23-7.
|
29 |
Figueroa AJ, Stein JP, Dickinson M, et al (1998). Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer, 83, 141-7.
DOI
|
30 |
Gupta P, Jain M, Kapoor R, Muruganandham K, Srivastava A and Mandhani A (2009). Impact of age and gender on the clinicopathological characteristics of bladder cancer. Indian J Urol, 25, 207-10.
DOI
|
31 |
Herr HW, Donat SM and Reuter VE (2007): Management of low grade papillary bladder tumors. J Urol, 178, 1201-5.
DOI
|
32 |
Hoke GP, Stone BA, Klein L and Williams KN (1999): The influence of gender on incidence and outcome of patients with bladder cancer in Harlem. J Natl Med Assoc, 91, 144-8.
|
33 |
Horstmann M, Witthuhn R, Falk M and Stenzl A (2008): Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med, 5, 385-94.
DOI
|
34 |
Jimenez RE, Gheiler E, Oskanian P, et al (2000). Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol, 24, 980-7.
DOI
|
35 |
La Vecchia C, Bosetti C, Lucchini F, et al (1975). Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol, 21, 1323-60.
|
36 |
Kakehi Y, Hirao Y, Kim WJ, et al (2010). Bladder Cancer Working Group report. Jpn J Clin Oncol, 40, 57-64.
DOI
|
37 |
Koyuncuer A: Immunohistochemical expression of p63, p53 in urinary bladder carcinoma (2013). Indian J Pathol Microbiol, 56, 10-5.
DOI
|
38 |
Lopez-Beltran A, Bassi P, Pavone-Macaluso M and Montironi R (2004). Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol, 45, 257-66.
DOI
|
39 |
Lippka Y, Patschan O, Todenhofer T, et al (2013). Bladder cancer discussed on the internet: a systematic analysis of gender differences of initial posters on an online discussion board. Springerplus, 2, 445.
DOI
|
40 |
Lopez-Beltran A, Sauter G , Gasser T, et al (2004). Tumours of the Urinary System. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors: World health organization classification of tumours pathology and genetics: tumours of the urinary system and male genital organs, IARC Press, Lyon, pp88-157.
|
41 |
Maruniak NA, Takezawa K, Murphy WM (2002). Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol, 167, 2404-7.
DOI
|
42 |
Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, et al (2000). Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol, 164, 680-4.
DOI
ScienceOn
|
43 |
Nielsen ME, Shariat SF, Karakiewicz PI, et al (2007). Bladder Cancer Research Consortium (BCRC). Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol, 51, 699-706.
DOI
|
44 |
Miyamoto H, Brimo F, Schultz L, et al (2010). Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Arch Pathol Lab Med, 134, 1160-3.
|
45 |
Mostofi FK, Sobin LH and Torloni H (1973). Histological typing of urinary bladder tumours. International Histological Classification of Tumors. No:10. WHO Geneva , Switzerlend, pp9-33.
|
46 |
Negri E and Vecchia CL (2007). Epidemiology and prevention of bladder cancer. In: Bassi PF, Pagano F, editors. Invasive Bladder Cancer. Springer, London, pp1-14.
|
47 |
Nomikos M, Pappas A, Kopaka ME, et al (2011). Urothelial carcinoma of the urinary bladder in young adults. Presentation, clinical behavior and outcome. Adv Urol, 480738.
|
48 |
Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, et al (2002). Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol, 55, 900-5.
DOI
|
49 |
Pan CC, Chang YH, Chen KK, et al (2010). Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am J Clin Pathol, 133, 788-95.
DOI
|
50 |
Parkin DM, Pisani P, Ferlay J (1999): Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 80, 827-41.
DOI
|